Evaluation of FFR and CPET in patients with de novo coronary chronic total occlusion treated with DCB vs. DES
BackgroundDrug-coated balloon (DCB) is a novel therapeutic strategy for de novo coronary chronic total occlusion (CTO). However, fractional flow reserve (FFR), a key indicator of evaluating coronary function, and cardiopulmonary exercise testing (CPET), an important indicator of cardiopulmonary func...
Saved in:
Main Authors: | Lingli Guo, Hengdao Liu, Xi Zhao, Ting Liu, Chenyang Gao, Jihao Duan, Dongfeng Wang, Junwei Zhao, Yuzhen Wei, Ruipeng Song, Hailong Tao |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-07-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2025.1584548/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Drug-eluting balloon as an alternative to coronary stent in the treatment of de novo atherosclerotic lesions of native coronary arteries — the future we have already been in? Review
by: D. K. Vasiliev, et al.
Published: (2025-07-01) -
Long term outcomes of drug-coated balloons versus drug-eluting stents in patients with small vessel coronary artery disease
by: Hesham Refaat, et al.
Published: (2025-07-01) -
JET+PCB strategy in the treatment of superficial femoral artery occlusion: a case report
by: F. B. Shukurov, et al.
Published: (2023-09-01) -
Modern approaches in the treatment of occlusive restenosis of the arteries of the lower extremities. Case report
by: S. V. Anisimov, et al.
Published: (2023-06-01) -
Efficacy and safety of drug-coated balloon angioplasty in proximal LAD stenosis with distal myocardial bridge: a 12-month comparative study with drug-eluting stents
by: Xi Wu, et al.
Published: (2025-07-01)